Skip to main content
. Author manuscript; available in PMC: 2012 Mar 10.
Published in final edited form as: Neuroscience. 2010 Dec 24;176:237–253. doi: 10.1016/j.neuroscience.2010.12.031

Fig 7.

Fig 7

(A) Plasma concentrations of DFP during a treatment regimen in which DFP was administered s.c. on alternate days over a 30 day period followed by a 14 day wash-out period. The arrows indicate days during which DFP was administered prior to removing the blood sample for analysis. Each value represents the mean ± S.E.M. derived from 6 rats. (B). Plasma cholinesterase activity as a percent of control during a treatment regimen in which DFP was administered s.c. on alternate days over a 30 day period followed by a 14 day wash-out period. The arrows indicate days during which DFP was administered prior to removing the blood sample for analysis. Each value represents the mean ± S.E.M. derived from 5-6 rats. (C) Brain acetylcholinesterase activity as a percent of control measured in 5 brain regions on the last day of a 30-day alternate injection regimen as well as in separate groups of animals at 7 and 14 days after the last DFP administration. Each value represents the mean ± S.E.M. derived from 5-6 rats. *p<0.05 with respect to vehicle control mean.